NOVARTIS PHARMACEUTICALS CORP. v. ABBOTT LABS., 03-1367, -1393
In a pharmaceutical patent dispute over a drug that helps prevent organ rejection in transplant patients, the court reversed on a claim construction issue, but affirmed a JMOL of non-infringement for the defendants.
- Decided 07/08/2004
- Published 07/08/2004
Before BRYSON, GAJARSA, and PROST, Circuit Judges.
United States Federal Circuit
Robert L. Baechtold,Fitzpatrick, Cella, Harper & Scinto, of New York, NY, argued for plaintiffs-appellants. With him on the brief were Nicholas N. Kallas, Stevan J. Bosses, and Diego Scambia.
Jeffrey I. Weinberger, Munger, Tolles & Olson LLP, of Los Angeles, CA, argued for defendant-cross appellant. With him on the brief were Ted G. Dane and Andrea Weiss Jeffries.